SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-065747
Filing Date
2021-03-02
Accepted
2021-03-02 17:18:59
Documents
13
Period of Report
2021-03-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d114694d8k.htm   iXBRL 8-K 25575
2 EX-99.1 d114694dex991.htm EX-99.1 4270
  Complete submission text file 0001193125-21-065747.txt   139576

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA neog-20210302.xsd EX-101.SCH 3062
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20210302_lab.xml EX-101.LAB 15317
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20210302_pre.xml EX-101.PRE 9660
6 EXTRACTED XBRL INSTANCE DOCUMENT d114694d8k_htm.xml XML 2920
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

IRS No.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 000-17988 | Film No.: 21705187
SIC: 2835 In Vitro & In Vivo Diagnostic Substances